Adenovirus Type 5 Interactions with Human Blood Cells May Compromise Systemic Delivery
Open Access
- 1 July 2006
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 14 (1) , 118-128
- https://doi.org/10.1016/j.ymthe.2006.01.003
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Tumor cell targeted gene delivery by adenovirus 5 vectors carrying knobless fibers with antibody-binding domainsGene Therapy, 2004
- Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in ratsMolecular Therapy, 2004
- Prostate specific membrane antigen (PSMA) is a tissue‐specific target for adenoviral transduction of prostate cancer in vitroThe Prostate, 2004
- Gene Transduction and Cell Entry Pathway of Fiber-Modified Adenovirus Type 5 Vectors Carrying Novel Endocytic Peptide Ligands Selected on Human Tracheal Glandular CellsJournal of Virology, 2004
- Virus-Directed Enzyme Prodrug Therapy: Intratumoral Administration of a Replication-Deficient Adenovirus Encoding Nitroreductase to Patients With Resectable Liver CancerJournal of Clinical Oncology, 2004
- A minimally invasive approach for efficient gene delivery to rodent heartsGene Therapy, 2004
- Titer determination of Ad5 in blood: a cautionary noteGene Therapy, 2003
- Adenovirus Serotype 5 Fiber Shaft InfluencesIn VivoGene Transfer in MiceHuman Gene Therapy, 2003
- Regulatory Approvals of Pediatric Oncology Drugs: Previous Experience and New InitiativesJournal of Clinical Oncology, 2003
- Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinomaCancer Gene Therapy, 2002